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The Role of Capillaries in the Lesser Ailments of Old Age
(muscle weakness, minor memory lapses, & cold intolerance)

and in Alzheimer’s Disease & Vascular Dementia:
the Potential of Pro-Therapeutic Angiogenesis

ABSTRACT … 164 words
Apart from chronic diseases (arthritis, diabetes, etc.), old age is generally characterized
by three lesser ailments: muscle weakness, minor memory lapses, and cold intolerance. This
trio of complaints may have a common, underlying cause -- namely, the age-associated reduced
microcirculation in muscles, brain, skin, and elsewhere in the body. The Angiogenesis
Hypothesis proposes that old age is in part a deficiency disease due to the decline in angiogenic
(AG) factors, resulting in a reduced capillary density (CD) throughout the body. Over fifty
published papers document waning levels of AG factors and/or decreased CD in various organ
systems of aged animals and people -- including those with Alzheimer’s disease. The deficiency
of AG factors is analogous to that of certain hormones (e.g., testosterone) whose blood levels
also decline with age. In theory, therapeutic angiogenesis employing recombinant AG factors is
a tenable treatment for the lesser ailments of old age and may improve the later years of human
life. An optimal administration route may be intranasal.

Keywords: aging, angiogenesis, capillary density, muscle weakness, memory lapses, cold
intolerance, vascular dementia, AD
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The Role of Capillaries in the Lesser Ailments of Old Age
(muscle weakness, minor memory lapses, & cold intolerance)

and in Alzheimer’s Disease & Vascular Dementia:
the Potential of Pro-Therapeutic Angiogenesis

1. Introduction
After years of relative good health, many long lived persons in their sixties or so begin
experiencing a trio of lesser ailments common to old age. The most conspicuous one is muscle
weakness and ready fatigue. More subtle are minor memory lapses, euphemistically termed
‘senior moments’. The third ailment is cold intolerance, which is evident in older persons
frequently feeling the need to ‘bundle up to stay warm’. Constipation and occasional difficulty
in swallowing are also complaints mentioned in the geriatric literature, but the three lesser
ailments are more frequent complaints.
The trio may be linked together through an age-associated microvascular change
discussed in several earlier papers for more serious conditions [1,2]. There, I summarized data
from the literature suggesting that Alzheimer’s disease (AD) and vascular dementia (VaD) are
due in part to diminished capillaries in the brain. Others had advanced the same idea [3-9]. This
histological change is usually expressed as a reduced ‘capillary density’ (CD) and was first
studied extensively in rat brains by E. Horne Craigie in the 1920s [10]. In 2003, Riddle et al.
reported that 14 of 21 studies on old people and old animals showed a reduced cerebral CD [11].
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And in 2011, based on 37 reports, Brown and Thore concluded that “there is strong evidence of
reduced vascular density” in the brains of aging animals and people, including those with AD
and a mouse model of AD [12]. While several early studies reported ‘increased’ cerebral CD or
‘no change’ in CD with aging, the “preponderance of studies” showed reduced values [12].
Tissue shrinkage may account for the discordant CD values, as discussed elsewhere [2].
My several reviews concerning capillary density have related the reduced CD to the
waning angiogenesis during aging [1,2]. By way of background, the capillary system emerges
during embryonic and post-natal life via a process termed vasculogenesis, in which the original
vessels are derived from endothelial stem cells under the influence of various angiogenic factors.
Later, the microcirculation develops via angiogenesis, in which capillary branches bud from the
early ones [13,14]. Additional angiogenesis occurs during the ovarian cycle and pregnancy.
Local angiogenesis is vital for wound healing, other injuries involving hypoxia, and possibly
capillary maintenance. But during the final phase of life, levels of angiogenic factors decline,
resulting in the reduced CD throughout the body.
One aspect of the reduction in CD and AG not commonly appreciated is that it is a
general phenomenon of aging -- occurring not only in the brain but in skeletal muscles, skin,
larynx, colon, kidneys, lungs, and vasa vasorum. This extensive change has implications beyond
AD and VaD which extend to aging -- the main concern of this essay.
Support for this general finding comes from over 50 published reports on aged people
and old animals exhibiting reduced CD and diminished AG factors collectively in nine organ
systems. CD and levels of AG factors from adults or mature animals have been paired with
comparable values from the aged for the following summaries. Presenting data pairs is more
persuasive than generalizing about reduced values. A reduction in CD is documented in 25 data
pairs obtained from people and 22 from animals [2, Tables 2 & 3; 15, Tables 1 & 2]. Similarly,
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an age-associated decline in AG is demonstrated in 8 data pairs derived from animals and 10
from people [15, Tables 3 & 4; also Table 3 below]. These 65 data pairs come from various
areas of the body.
The reduction of CD is not associated with any environmental influence but, again, is
determined by angiogenic factors, whose levels throughout the body are genetically programmed
from embryonic development on and change like hormones at different stages of life. Unlike
hormones, AG factors are produced by various cell types throughout the body -- fibroblasts,
mononuclear cells, platelets, muscles, tumor cells, etc. Three angiogenic factors commonly
studied are vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and
angiogenin (Ang) -- all of which have been reviewed elsewhere [16,17].
Extensive data on CD and AG in the brain and muscles were presented in my earlier
reviews [1,2,15]. Only representative data pairs from them are included in Tables 1 & 2 and the
text of this essay in order to limit its length and avoid the charge of self-plagiarism [18]. Data
pairs only recently found in reports on other organ systems are listed in Table 3 and discussed
below. Later sections consider the significance of all these data for treatment of the lesser
ailments of the aged and the more serious problems of cognition.

2. Muscle weakness
The waning muscle strength experienced by older persons generally reflects the loss of
muscle mass (sarcopenia), which is due in part to decreased exercise but is a natural consequence
of aging [19,20]. An underlying cause is a reduced microcirculation. Eighteen published reports
showing reduced capillary density and declining angiogenic factors in the leg muscles of aged
people and animals have been summarized elsewhere [15, Tables 1-4]. Data from only three
such reports are listed in Table 1 and discussed immediately below.
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Capillary density. This has commonly been measured as the sum of capillary lengths
per section of tissue (mm/mm3). Coggan et al. examined the CD of the lateral gastrocnemius
muscles of young persons (24 ±1yrs) and the old (64±1yrs) and noted a reduction from 308±16
in young males to 228±13 in older men and from 338±19 in young females to 248±12 in older
women [21]. Numerous other investigators have obtained similar data [22-24]
Reductions in CD have been recorded in the hind limbs of various aged animals: dogs,
rabbits, rats, and mice [25-27]. Rivard and associates presented findings in several tables from
which were derived the following data pairs: the av. values for capillaries/mm3 in 6-8 month old
rabbits was 170 and for those 4-5 years old was 130 [28, Fig. 5G]. In mice the values were 710
at 12 weeks of age and 350 at 2 years [28, Fig. 5H].
Angiogenic factors. Again, capillary density in muscles is determined by the local levels
of AG factors. Levels of vascular endothelial growth factor (VEGF), basic fibroblast growth
factor (bFGF), and platelet derived growth factor (PDGF) have been measured in men and mice
of different ages [men: 24,29-31; mice: 28,32-33]. For example, in studies on the vastus
lateralis muscle, Ryan et al. found that at rest VEGF protein levels were 1.05 in young men (age
19-25 yrs.) but only 0.55 in old men (60-72 yrs.) [24]. Similarly, the 18s mRNA VEGF level was
1.0 in the young men but only 0.4 in old men [24]. In muscles of mice, Wagatsuma et al.
reported VEGF levels of 1.0 in the young ones (2.5 mo.) and only 0.7 in the old ( 22 mo.) [33].
Thus, in these examples and other studies, the values were consistently lower in the aged.
Exercise. Exercise elicits local angiogenesis around muscles and a transient increase in
local capillary density . There are 21 reports documenting this response -- 15 in people and 6 in
animals [15, Table 5]. In the study cited above, Ryan et al. found that four hours after exercise
the values for VEGF mRNA rose to 3.4 in young men but only to 1.8 in old men [24]. After
exercise, the levels of VEGF protein rose less in older men than in younger ones. Other
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investigators have found the same age-discrepancy in CD/AG responses following exercise
[34,35]. In any case, there now is a firm physiological basis for the ‘morning constitutional’ to
help maintain lower body strength. Also any AG factors released into the circulation while
walking might reach the brain and improve cerebral microcirculation and possibly cognition.

3. Brain: Minor Memory Lapses … capillary blood flow
In older adults, forgetting momentarily a familiar word or name, which seems ‘on the tip
of the tongue’, is defined as a ‘retrieval block’ [36]. A simple explanation here is that compared
to youngsters, most elderly persons simply have a larger data base in their brain from having
absorbed so much information over many decades of a long life. To be recalled, a particular
word or name competes, so to speak, with billions of other memories residing somewhere among
the billions of synapses. A particular book may be found quickly in a small library but takes
longer in a large one. Or as one commentator wrote, “It’s not that you’re slow … you know so
much” [37]. Challenging this interpretation are those rare individuals diagnosed with a ‘highly
superior autobiographical memory’ (HSAM), who can recall in infinite detail the countless
events experienced throughout their daily life [38]. There is no report of their having more
frequent memory lapses.
The exact mechanism eliciting recall of a word or name remains a mystery but involves
specific neurons whose synapses when ‘fired’/engaged can evoke a particular memory in one’s
consciousness [36]. In AD and VaD, the loss of various memories is believed due to the death
or irreversible malfunction of key neurons, thus accounting for the absent synaptic responses.
But in persons having ‘a senior moment’, the blocked word or name is generally recalled later,
indicating that the relevant neurons are intact but their ability to induce synaptic responses is
momentarily impaired. Theoretically, this could be due to a transient ischemia at the synaptic
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site responsible for a particular memory trace. But how could ischemia in the brain be limited to
a tiny area and be transient?
Capillary Blood Flow. A controversial issue several decades ago concerned whether
capillaries in the brain have a steady flow of blood at all times or whether some may have a
variable, reduced flow sometimes. Kuschinsky & Paulson concluded that all capillaries exhibit
100% flow at all times [39]. But other investigators have found reduced flow rates and varying
values in different areas -- 84% by Collins et al., 70-80% by Kikano et al., and 50% by Weiss
[40-42]. While different assay methods may account for the differing results, this uncertainty
suggests that blood flow in individual capillaries may indeed vary. A transient, diminished local
capillary blood flow and the resultant lowered glucose or oxygen supply might limit the
excitation of the synapses involved in a particular memory and account for its momentary lapse
or pause. But what might explain such a transient local change in the elderly?
Stress. Here I’m reminded of my own recent memory lapses at age 86. Over the past
year or so, I’ve experienced them occasionally during lectures to medical students and also in
serious or spirited conversations. These lapses are often masked by my using synonyms or some
circumlocution. Just as my muscle strength and muscle reserve are now decidedly less than
formerly, so too may be my ‘cognitive reserve’ [2,43]. Perhaps in an elderly person a slight
emotional stress may divert the microcirculation momentarily and by chance from a specific area
of memory recall to an area where blood flow is more critical -- e.g., to some other region of the
brain or to the heart.

4. Brain: Major Cognitive Deficiencies … capillary density
It’s unknown whether the occasional memory pauses in older persons portend the more
serious cognitive decline seen later in them. Different mechanisms seem probable. In contrast to
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the transient memory lapses, the mental deterioration seen in the aged is generally progressive
and permanent and is believed due to neurons lost or impaired, resulting from cerebral vascular
insufficiency. One cause of a permanently reduced cerebral blood flow (CBF) would be a
reduced number of cerebral capillaries. Groups concerned with the overall/gross CBF (like
Grossman et al.) have measured it with various imaging modalities or bolus fractional methods,
but few of them have also assessed capillary cerebral blood flow, like Desjardins et al.[44,45].
Capillary density. Available in a previous publication are the data from 23 studies
showing reduced numbers of capillaries in the aged: 5 reports in older persons, 5 reports in those
with Alzheimer’s disease, and 13 reports in aged rats and mice [2, Tables 2 & 3]. In this essay it
will suffice to list in Table 2 representative CD data from three such reports on the brain. The
six data pairs (young vs. old) are briefly discussed in the text below -- first those from people and
then from rats.
Mann et al. compared the sum of capillary lengths/section (mm/mm3) in the frontal cortex
and found the average CD there for six adults ages 26-58 years to be 965.5 ± 133, while that for
nine adults ages 76-96 years was only 783.6 ±56 [46].

Fischer et al. compared the ‘vascular

density index’ in the brains of 6 persons aged 23-90 with that in 16 AD patients aged 76-92.
These authors reported average values in the prefrontal cortex: 94.6 vs. 75.4, in the basal
forebrain: 86.8 vs. 42.7, and in the hippocampus: 82.3 vs. 50.2 [47].
Likewise, Buchweitz-Milton and Weiss measured cerebral CD in adult rats (8-10
months) versus old rats (21-33 months) and found values in the cortex of 830±115 vs. 577±36
and in all six brain areas of 837 ±54 vs. 592 ± 22 [48].
Angiogenesis. So far as I am aware, there are no published data on levels of AG factors
in the brains of aging persons, but there is one study in old animals. Vascular endothelial growth
factor (VEGF) has been reported diminished in the parietal cortex of rats, declining from 32.2
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pg/mg protein in young rats to 22.5 pf/mg protein in old ones [49]. The reduced VEGF in the
brains of old rats noted here and similar findings in human muscles reviewed in the preceding
section suggest that a comparable reduction of AG factors in the human brain may be found
when specifically looked for in persons with VaD and AD.

5. Skin: Cold Intolerance and reduced CD
Elderly persons complain that they sometimes feel chilly all over or that their fingers and
feet are cold to the touch. These conditions could be termed dysthermia or ‘krymoesthesia’
(krymo, Gr. = cold; esthesia, Gr. = feeling). Internet web sites addressing this issue have
invoked hypothyroidism or social isolation as causes. Review papers in the geriatric literature
have focused on lower limb temperature fluctuations, thermal sensitivity/perception, or preferred
room temperatures [50-52]. ‘Cold feelings’ in the elderly may be due to two conditions in the
subcutaneous tissues: transient vasoconstriction of arterioles there and reduced local fat. Both
conditions may be linked to a reduced microcirculation in the subcutaneous tissues, as explained
later.
In a related vein, I haven’t found a clear explanation in the literature of why during the
spring and late fall in the northern US states that many older adults go about well bundled up
with gloves and earmuffs, while young people walk around in shorts and light clothing. The
contrast between ages may reflect youthful exhibitionism. But a physiological explanation for
cold intolerance may involve the insulating function of subcutaneous adipose tissue.
Adipose tissue is located predominantly in two areas of the body -- under the skin as
subcutaneous adipose (SA) and surrounding the viscera in the peritoneal cavity as visceral
adipose (VA). Adipose tissue is the only adult tissue which can grow/increase and regress any
time throughout adulthood [53]. It is highly vascularized and its level in either area is controlled
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by angiogenesis. SA shows greater CD and AG levels than VA [54]. Silha et al. reported
increased levels of vascular endothelial growth factors in obese subjects [55].
Subcutaneous adipose may exert two functions in the body -- insulating it against the cold
and cushioning/supporting the overlying skin. The former function may help explain cold
intolerance of the aged, who have reduced SA. The latter function involves fat filling
subcutaneous spaces and keeping the skin free of wrinkles. In old age when SA is lost, wrinkles
invariably appear on the back of the hand, where engorged veins become conspicuous. But why
and when might SA be lost?
Capillary density. In Table 3 are three reports of CD in the skin of mature and old
persons. Helmbold et al. obtained biopsies from the trunk area and found CD in the upper
dermal plexus of 4.3/hpf (high power field) for those 30-49 years of age and 1.4/hpf for persons
over 70 years of age [56]. Vybohova et al. measured the percent capillary area in papillary
dermis from the anterior thoracic region of cadavers and reported values of 1.42% for subjects
age 31-51 and 0.63% for those 71-80 years [57]. And in the ears of hairless rats, Vollmar et al.
found values for the cutaneous capillary density of 77.6 cm/cm2 for 30 weeks old rats versus
37.5 cm/cm2 for 78 week old ones -- a 40% reduction [58].
In summary, the reduced CD in the skin of old persons presumably reflects a decreased
level of angiogensis, which in turn would account for their diminished subcutaneous adipose,
cold intolerance, and a conspicuous sign of aging -- skin wrinkles.

6. Other Areas with Reduced CD and Diminished AG
Organ systems other than the brain, leg muscles, and skin also show functional declines
with age in parallel with a reduced CD and/or lower levels of AG factors.
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Larynx. Dysphagia could be considered the fourth ‘lesser ailment of the elderly’, since
difficulty in swallowing (notably large pills) occurs in 15% to 40% of those over 60 years of age
[59]. Dysphagia is thought due to sarcopenia. Russell et al. reported a reduced capillary density
in the thyroarytenoid muscles of old rats (28-30 mo.) compared with adult ones (9 mo.):
declining from 17.0 to 9.35 [60]. A resulting loss of laryngeal muscle mass could affect both
phonation and deglutition.
Colon. The taenia coli are three longitudinal ribbons of smooth muscles on the outside
of the colon whose contractions stimulate gut motility and tone. Gabella reported a substantial
fall in the ‘capillary profile’ in the colon of aged guinea pigs compared to young one -- a
reduction from 9 capillary/10,000 m2 in young adults to “less than 5 in the aged animal” [61].
A common complaint of elderly people is constipation [62]. If a similarly reduced CD occurs in
the colon of older people, perhaps this could contribute to their costive bowel problems.
Kidney. Three studies involving old mice and old rats show reduced capillaries in the
cortex and medulla of the kidney, as summarized here in Table 3 [63-65]. For example, Kang et
al. found an age-associated reduced “capillary staining” in the peritubular area of the rat kidney:
39.3% in 3-month old rats and 19.2% in 24-month old rats. They also noted decreased VEGF
expression in the kidney medulla of aging rats: 11.3% (3 mo.) and only 5.4% (24 mo.) [65].
These authors wrote that the peritubular capillary loss and the declining VEGF expression
“strongly correlate with the degree of glomerulosclerosis” and other pathology in rat kidneys.
Lung. Older persons show an age-related reduction in the diffusion capacity of their
lungs, which reflects in part a reduction in the “ lung blood capillaries” [66]. Alveolar-capillary
clearance rates (% per minute) were measured by Braga et al. in the three age groups: <30, 3135, >56 yrs [66]. They found a progressive decline of 1.38%  1.08%  0.76%,
respectively. In 1959 McGrath and Thompson measured the diffusing capacity for carbon
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monoxide (DCO) in the lungs of three groups of normal men -- ages 17-36, 38-58, and 60-75 [67].
To take into account differing lung size, I calculated an adjusted value for lung capillaries by
dividing the average DCO of each group by each one’s respective average vital capacity. This
yielded an age-linked declining set of values -- 0 .86  0.73  0.51 for the above three age
groups.
Vasa vasorum. This is a network of capillaries supplying the walls of large blood
vessels, such as the aorta and vena cava. Phillips et al. reported that these capillaries in the rat
femoral artery “were dramatically reduced in number by 12 months, and even fewer were present
at 24 months” [68]. The authors speculated that this reduced CD in arteries in people “may
explain why the aged are more prone to atherosclerosis.”
Peripheral blood mononuclear cells. Solerte et al. determined the level of VEGF in
peripheral blood mononuclear cells from three groups: healthy young adults (average age, 32.2
years), old subjects (77 years), and persons with AD (76.5 years). The values were, respectively,
296 pg/ml, 137 pg/ml, and 125 pg/ml [69]. This study concerned the role of immune cells in AD
and produced the above data, which, parenthetically, is applicable to the thesis of this essay.
Liver. Age-linked changes in capillaries may likely be found in other organ systems
when examined for them, as suggested earlier. One such example is ‘pseudocapsillarization’ in
the liver of aged people and animals [70-72]. Here the liver sinusoidal endothelial cells are
thickened and show reduced fenestration (porosity). These changes likely contribute to ageassociated hepatic impairment and may be related to the reduced CD seen elsewhere in the aged.

7. The Angiogenesis Hypothesis: Correlation vs. Causation
The above data from nine organ systems underlie the Angiogenesis Hypothesis of Aging.
It proposes that a reduced angiogenesis throughout the body accounts in part for the lesser
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ailments of early old age and for the more serious cognitive deficits in later life. A central issue
in the hypothesis is whether the reduced capillary density (reduced microcirculation) causes
these hallmarks of aging or whether the reduced CD is coincidental [73]. Several of the five
reports noted below provide support for the hypothesis, while others suggest studies to determine
its validity.
1) Physiological aging in people is evident by numerous signs and symptoms -- e.g.,
wrinkles in the skin, the LAs, and dementias. The development of these hallmarks of aging
varies from person to person, reflecting genetic backgrounds and life habits. A reduced CD at
some one point in time and the presence then of some physical sign of aging does not establish
that the former caused the latter. However, if the progressive decline in CD over time parallels
the gradual emergence of some hallmark of aging in an individual or group, then the case for
cause-and-effect would be stronger. Degens et al. measured CD/mm2 and the fiber number in
the plantaris muscle of rats of age 5 mo., 13 mo. and 25 mo. The CD values fell progressively:
with age: 1000  850  700, while the fiber number (muscle mass) decreased between months
13 and 25 [26, ex. Fig. 4].
2) Most reports which have compared CD or AG in the young and old have determined
values at only two dates and in two different populations. But a study by Frontera et al.
measured muscle strength in a cohort of 8 men over a 12 year period. The cohort exhibited a
28.5% decline in 60o knee flexion of the vastus lateralis muscle over 12 years and a 20.3%
reduction in the muscle’s capillary density -- from 1.39 to 1.08 [19]. Unfortunately, the men
were not tested at intervals to provide intermediate data points for a hypothetical graph relating
CD with degrees of flexion.
3) Support for the AG hypothesis might come from retrospective CD measurements in
brain collections like that of the Nun Study, created by David Snowdon and continued over
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several decades [74]. Six hundred nuns were enlisted and assessed during their later years for
their cognitive status. Over 500 brains from this cohort are available for histological study.
Whether a reduced cerebral CD correlates with cognitive decline could be determined by
comparing CD in the brains of two groups of nuns: those who remained cognitive normal
throughout old age and those who showed evidence of dementia.
4) A different approach for establishing cause and effect would be to administer a
naturally occurring regulatory factor which declines during old age (e.g., VEGF, etc.) and to
show that this treatment improves some feature of aging or arrests its natural development. For
example, Wang et al. found that exogenous VEGF improved the cognitive function of transgenic
AD mice [75]. Morris water maze tests showed that mice given daily intraperitoneal injections
of VEGF for three day subsequently exhibited improved learning and memory. Blood vessels
also increased in the hippocampus but gradually declined after the second week.
5) In a remarkable study involving angiogenesis and cognition, Harry S. Goldsmith
exploited a rich natural source of AG factors -- the omentum, which cushions the abdominal
viscera. An omental pedicle was surgically transpositioned under the skin and stretched to reach
and cover part of the brain surface in each of 25 AD patients. Ten showed slight cognitive
improvement, while “nine demonstrated marked cognitive increases,” presumably as a result of
the pedicles supplying AG factors to the brain and improving the cerebral microcirculation [76].
The practical import of the angiogenesis hypothesis is its corollary that treatment of the
aged with recombinant AG factors (= therapeutic angiogenesis) might reverse the age-linked
decline in AG and CD, relieve the lesser ailments of old age, and delay/reduce later cognitive
changes.

8. Theories of Aging and Anti-aging Therapies
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A general science writer once concluded that there seems to be a theory on aging for
every published investigator [77]. Gerontologists have previously ascribed the physical and
mental decline of old age to the various causes listed in Table 4 [78-83]. The hypothesis
presented in this essay is a new addition to that list. As noted in the introduction, numerous
groups have proposed a vascular deficiency in the brain for Alzheimer’s disease and other senile
dementias. However, so far as I am aware, no group has invoked a reduced CD throughout the
body in many organ systems to account for the general signs and symptoms of aging -including the lesser ailments, the dementias, and declining organ functions. This essay proposes
that a declining angiogenesis throughout the body contributes significantly to aging but allows
that other influences may also exist. Even if aging is a multifactorial process, relieving one of
the cumulative causes by therapeutic angiogenesis would have a beneficial effect on the elderly.
The numerous theories of aging outlined in Table 4 can be considered under two broad
causes: stochastic (random) versus developmental (genetic). They range from the obvious
dangers of daily life (diseases, stress, toxins, et al.) to the modern biological discoveries (somatic
mutations, telomere shortening, stem cell loss, et al.).
Anti-aging Therapies. Many theories of aging seem scientifically plausible but suggest
no feasible means of relieving the signs and symptoms of the aged -- or at least by any measure
currently available for general use. Examples are those notions invoking a biological clock,
chemical cross linking, defective transcription, etc. On the other hand, some ideas infer the use
of available natural agents to treat medical condition of the aged. For example, one theory
suggested that cholinesterase inhibitors (ChEIs) might ameliorate cognitive decline of old age,
but clinical trials with these agents have been disappointing [84-87]. Another theory postulated
that oxidative stress due to oxygen free radicals accumulating in the tissues accelerates aging.
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But treatments with various antioxidants (Ginkgo biloba, teas, flavonoids, vitamin E, etc.) have
yielded conflicting results [88]. Anti-aging studies have also considered hormonal deficiencies.
Correcting Deficiency States. The loss of muscle strength during old age has been
associated with decreasing levels of growth hormone and various sex hormones. But the
administration of these agents has “not been uniformly proven to be safe and of benefit” [89].
Parenthetically, there is evidence that “androgens regulate angiogenesis” [90]. For example,
dihydrotestosterone induces VEGF secretion from fibroblasts of young men but not from those
of older men ]90]. An age-linked declining level of testosterone or other hormones may have a
secondary influence on AG. However, therapeutic angiogenesis with recombinant AG growth
factors seems a more direct treatment of the AG deficiency of old age.

9. Pro-Therapeutic Angiogenesis
Therapies involving capillaries have employed opposite approaches in exploiting
angiogenesis -- anti-AG and pro-AG. Anti-angiogenesis has been pursued for correcting those
conditions where AG has had a harmful effect -- e.g., promoting growth of tumors or diabetic
retinopathy. Anti-angiogenesis trials have sought to suppress the action of a single factor -- e.g.,
VEGF with bevacizumab, an anti-VEGF antibody [91].
Pro-angiogenesis concerns those conditions involving a deficient microcirculation among
other circulatory problems -- e.g., cardiac insufficiency, intermittent claudication, cerebral
infarcts, diabetic ischemia, etc. Included here could also be the lesser ailments of old age. The
therapeutic potential of pro-angiogenesis has been widely acknowledged for some time. In a
2011 paper, Peter Carmeliet and Rakesh Jain wrote, “The revascularization of ischaemic tissues
would benefit millions, but therapeutic angiogenesis remains an unmet medical need” [92].
Other investigators have reached the same conclusion [93-96]. Pro-AG would seem more
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complicated than anti-AG, since the former is believed to involve the coordinated action of
several factors.
Heinl-Green et al. suggested using a ‘master switch’ for the AG cascade, such as hypoxia
inducible factor (HIF), which is now available in a recombinant form [97]. Because HIF-1 is
rapidly degraded in the body, it was presented as a plasmid or encoded by adenovirus (Ad2) for
administration to experimental animals. The latter (Ad2HIV) has produced transient
revascularization in a porcine model of chronic myocardial ischemia [97]. A clinical trial using
Ad2HIV-1a/VP16 was undertaken in patients with intermittent claudication [98]. Clinical trials
have also sought to define the role of HIF-1 in cancer progression [99,100]. The long term
outcomes of these studies may have some relevance to easing the downward course of aging.
Selecting the correct AG factor/s for administration in human studies is a challenge,
although VEGF, FGF, and Ang separately have been safely used in short term clinical trials
involving cardiac insufficiency and intermittent claudication [13,17,101,102]. In animal models
of hind limb ischemia, Asahara et al. found a synergistic effect between VEGF and FGF [103].
However, treatment with a single ‘primary’ AG factor might suffice if all the other sequentially
involved factors were endogenously available. Michael Simons speculated, “All that needs be
done is to initiate the process of vascular growth, and nature will take its course” [13]. This may
have been the unstated rationale for administering a single AG factor in the clinical trials
mentioned above.
These clinical trials tested VEGF or FGF by injecting bolus amounts for short intervals
directly to the affected area (heart, legs) or by administering them systemically for limited
periods [104,105]. The absence of long term benefits in these studies may reflect these brief
courses of treatment. The lesser ailments of old age may require daily therapy, much like
treating a hormonal deficiency, such as hypothyroidism. Elsewhere I have discussed the
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advantage of administering recombinant AG factor in nasal drops, sprays, or nicotine-free snuff
[2,106].

10. Summary
Barring a fatal accident (trauma, poisoning) or an early terminal illness (cancer, stroke,
etc.), long-lived persons will likely experience the lesser ailments of old age before developing
serious cognitive problems and finally dying of pneumonia, cardiac failure, etc. In 1994, Daniel
A. Drachman considered a later threat to the elderly in an article entitled, “If we live long
enough, will we all be demented?” [107]. Theoretically, a further reduction in the cerebral CD
would lead to this condition in the very aged.
Finally, this essay proposes that as people (and animals) age, angiogenesis wanes
throughout the body and the microcirculation declines in most or all organ systems. Old age is
viewed here in part as an age-linked deficiency state of angiogenic growth factors. In elderly
people the lesser ailments generally appear first, while more serious cognitive problems may
follow from a further decline or imbalance of these factors. Various organ systems decline in
function or fail in time -- hormonal, renal, cardiac, etc. Regular administration of low levels of
selected recombinant angiogenic factors seems a tenable treatment to consider for the above
hallmarks of aging.
End
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Table 1. MUSCLE

Muscle -- CD
-- Cogan [21]
-- male
-- female
-- Rivard [28]
-- rabbits
-- mice
Muscle -- AG
-- Ryan [24]
-- men … VEGF protein
-- men … mRNA VEGF
-- men exercise … mRNA VEGF
-- Wagatsuma [33]
-- mice

YOUNG

OLD

308 (av. 24 y.)
338
“

228 (av. 64 y.)
248
“

170 (6-8 m.)
710 (12 w.)

130 (4-5 y.)
350 (2 y.)

1.05 (19-25 y.)
1.0
“
3.4
“

0.55 (60-72 y.)
0.4
“
1.8
“

1.0 (av. 2.5 m.)

0.7 (22 m.)

Table 2. BRAIN
YOUNG

OLD (AD)

Brain -- CD
-- Mann [46]
-- people … frontal cortex

966 (26-58 y.)

784 (76-96 y.)

-- Fisher [47] … normal subjects vs. AD
-- pre-frontal cortex
-- basal forebrain
-- hippocampus

94.6 (23-90 y.)
86.8
“
82.3
“

75.4 (AD, 76-92 y.)
42.7
“
50.2
“

-- Buchweitz-Milton [48]
-- rats … cortex
-- rats … 6 brain areas

830 (8-10 m.)
837
“

577 (21-33 m.)
592
“

Brain -- AG
-- Viboolvorakul [49]
-- rats … parietal cortex

32.3 (4-6 m.)

20.5 (23-24 m.)

Table 3. SKIN & OTHER SITES
ADULT
SKIN -- CD
-- Helmbold [56]
-- human
-- Vybohova [57]
-- human CD, %/unit area
-- Vollmer [58]
-- hairless rat ear, CD
LARYNX -- CD
-- Russell [60]
-- rat thyroarytenoid muscle

4.4

(15-20 & 39-40 yr.)

OLD

2.3 (>70 yr.)

1.42 (31-50 yr.)

0.47 (81-89 yr.)

77.6 (30 wk.)

37.5 (78 wk.)

17.0 (9 mo.)

9.35 (28-30 mo.)

COLON -- CD

-- Gabella [61]
-- guinea pig … taenia coli

9 /unit area (n.d.)

5 /unit area (n.d.)

1.40 (3 mo.)
1.52 “

0.93 (27 mo.)
1.04
“

30 (6 mo.)

17 (18-22 mo.)

(longitudinal muscles of colon)

KIDNEY -- CD & AG
-- Stefanska [63]
-- mouse kidney cortex, CD
-- mouse kidney medulla, CD
-- Urbieta-Caceres [64]
-- mouse renal cortex, CD
-- Kang [65]
-- rat kidney, peritubular, capillary staining
-- rat, kidney medulla, VEGF expression

11.3% (3 mo.)

39.3% “

LUNG -- DCO / VC ≅ CD
-- McGrath [67]
-- human diffusion capacity for CO, corrected 0.84 (18-36 yr.)
(corrected for lung size, using DCO / vital capacity )
0.73 (38-57 yr.)
VASA VASORUM -- CD
-- Phillips [68]
-- rat femoral artery .. compared with 2 mo. ‘reduced’ (12 mo.)
MONONUCLEAR CELLS -- AG
-- Solerte [69]
-- human, VEGF

296 (av. 32.2 yr.)

5.4% (24 mo.)

19.2% “

0.51 (58-75 yr.)

more reduced (24 mo.)

137 (av. 77 yr.)
125 (AD, av. 76.5 yr.)

** For the sake of simplicity, margins of error and units of measurement are omitted here. Only
the senior author of papers is cited. … m. = months … y. = years … AD = Alzheimer’s disease
n.d. = not defined

Table 4. Causes of Aging … reviews [60-65]

A. Stochastic (random, chance) / organismal / function systemic / environmental
-- cumulative diseases: cancer, diabetes, hypertension, stroke, etc.
-- infectious diseases
-- chronic, low grade inflammation
-- accumulated environmental toxins (Clinker Theory)
-- intestinal toxins (Eli Metchnikoff)
-- defective clearance of effete cells and internal products
-- defective protein synthesis (1963 Orgel’s Error Hypothesis)
-- chemical cross linking
-- general stress … wear & tear (Hans Selye)
-- oxidative damage … free radical toxicity
-- radiation … chromosomal breaks
-- defective DNA repair
-- epigenetic modification

B. Developmental-genetic / molecular-cellular / intrinsic / endogenous / programmed
-- biological clock … longevity gene
-- cellular senescence ... programmed cell death … apoptosis
-- telomere shortening

-- loss of stem cell renewal
-- somatic mutations … genetic instability … defective DNA, RNA, proteins
-- defective transcription … (Codon Restriction Theory)
-- dysfunctional mitochondria
-- defective autosomal-lysosomal system
-- reduced autophagy efficiency … defective cellular clearance
-- altered immune system … impaired immune surveillance (thymic atrophy)
-- altered histo-incompatibility … increasing autoimmunity
-- neuroendocrine deficiency … waning hormones & receptors
-- age-associated declining angiogenic factors … Angiogenesis Hypothesis

